# Primis Financial Corp.: financial statements, quarterly

FRST · Nasdaq · CIK 1325670 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/frst.md) · [Financials](/companies/frst/financials.md) · [Filings](/companies/frst/filings.md) · [Insiders](/companies/frst/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/frst/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [23.7](/filings/0001558370-24-016161.md) | [24.4 d](/filings/0001558370-24-013277.md) | [25.1](/filings/0001558370-24-013697.md) | [27.3](/filings/0001558370-24-016160.md) | [29.1](/filings/0001558370-24-016161.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.5](/filings/0001558370-24-016161.md) | [(4.5) d](/filings/0001104659-26-028599.md) | [0.7](/filings/0001558370-25-007623.md) | [1.3](/filings/0001558370-25-011083.md) | [(0.3)](/filings/0001104659-25-109181.md) | [(5.9) d](/filings/0001104659-26-028599.md) | [5.6](/filings/0001104659-26-057998.md) | [0.5](/filings/0001104659-26-092672.md) | [1.9](/filings/0001104659-25-109181.md) | [6.7 d](/filings/0001104659-26-028599.md) | [3.0](/filings/0001104659-26-057998.md) | [2.7](/filings/0001104659-26-092672.md) |
| Net income | $m | [(6.0)](/filings/0001558370-24-016161.md) | [(8.2) d](/filings/0001104659-26-028599.md) | [2.5](/filings/0001558370-25-007623.md) | [3.4](/filings/0001558370-25-011083.md) | [1.2](/filings/0001104659-25-109181.md) | [(23.3) d](/filings/0001104659-26-028599.md) | [22.6](/filings/0001104659-26-057998.md) | [2.4](/filings/0001104659-26-092672.md) | [6.8](/filings/0001104659-25-109181.md) | [29.5 d](/filings/0001104659-26-028599.md) | [7.3](/filings/0001104659-26-057998.md) | [9.4](/filings/0001104659-26-092672.md) |
| Diluted EPS | $ per share | [(0.24)](/filings/0001558370-24-016161.md) | not reported | [0.10](/filings/0001558370-25-007623.md) | [0.14](/filings/0001558370-25-011083.md) | [0.05](/filings/0001104659-25-109181.md) | not reported | [0.92](/filings/0001104659-26-057998.md) | [0.10](/filings/0001104659-26-092672.md) | [0.28](/filings/0001104659-25-109181.md) | not reported | [0.30](/filings/0001104659-26-057998.md) | [0.38](/filings/0001104659-26-092672.md) |
| Basic EPS | $ per share | [(0.24)](/filings/0001558370-24-016161.md) | not reported | [0.10](/filings/0001558370-25-007623.md) | [0.14](/filings/0001558370-25-011083.md) | [0.05](/filings/0001104659-25-109181.md) | not reported | [0.92](/filings/0001104659-26-057998.md) | [0.10](/filings/0001104659-26-092672.md) | [0.28](/filings/0001104659-25-109181.md) | not reported | [0.30](/filings/0001104659-26-057998.md) | [0.38](/filings/0001104659-26-092672.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [93.9](/filings/0001558370-24-015047.md) | [77.6](/filings/0001558370-25-005861.md) | [88.7](/filings/0001558370-24-013697.md) | [66.6](/filings/0001558370-24-016160.md) | [77.3](/filings/0001558370-24-016161.md) | [64.5](/filings/0001104659-26-028599.md) | [57.0](/filings/0001558370-25-007623.md) | [94.1](/filings/0001558370-25-011083.md) | [63.9](/filings/0001104659-25-109181.md) | [144](/filings/0001104659-26-092672.md) | [160](/filings/0001104659-26-057998.md) | [177](/filings/0001104659-26-092672.md) |
| Total assets | $m | [3,839](/filings/0001558370-24-016161.md) | [3,857](/filings/0001104659-26-028599.md) | [3,890](/filings/0001558370-25-007623.md) | [3,966](/filings/0001558370-25-011083.md) | [4,024](/filings/0001104659-25-109181.md) | [3,690](/filings/0001104659-26-028599.md) | [3,697](/filings/0001104659-26-057998.md) | [3,872](/filings/0001104659-26-092672.md) | [3,955](/filings/0001104659-25-109181.md) | [4,047](/filings/0001104659-26-092672.md) | [4,257](/filings/0001104659-26-057998.md) | [4,354](/filings/0001104659-26-092672.md) |
| Total liabilities | $m | [3,461](/filings/0001558370-24-015047.md) | [3,459](/filings/0001558370-25-005861.md) | [3,495](/filings/0001558370-24-013697.md) | [3,572](/filings/0001558370-24-016160.md) | [3,627](/filings/0001558370-24-016161.md) | [3,325](/filings/0001104659-26-028599.md) | [3,322](/filings/0001558370-25-007623.md) | [3,495](/filings/0001558370-25-011083.md) | [3,573](/filings/0001104659-25-109181.md) | [3,624](/filings/0001104659-26-092672.md) | [3,829](/filings/0001104659-26-057998.md) | [3,920](/filings/0001104659-26-092672.md) |
| Shareholders' equity | $m | [378](/filings/0001558370-24-015047.md) | [376](/filings/0001558370-25-005861.md) | [375](/filings/0001558370-24-013697.md) | [376](/filings/0001558370-24-016160.md) | [381](/filings/0001558370-24-016161.md) | [352](/filings/0001104659-26-028599.md) | [376](/filings/0001558370-25-007623.md) | [376](/filings/0001558370-25-011083.md) | [382](/filings/0001104659-25-109181.md) | [423](/filings/0001104659-26-028599.md) | [427](/filings/0001104659-26-092672.md) | [434](/filings/0001104659-26-092672.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.9) d](/filings/0001558370-24-016161.md) | [65.4 d](/filings/0001104659-26-028599.md) | [(1.0)](/filings/0001558370-25-007623.md) | [52.3 d](/filings/0001558370-25-011083.md) | [6.1 d](/filings/0001104659-25-109181.md) | [(37.8) d](/filings/0001104659-26-028599.md) | [34.4](/filings/0001104659-26-057998.md) | [(41.0) d](/filings/0001104659-26-092672.md) | [(11.4) d](/filings/0001104659-25-109181.md) | [28.7 d](/filings/0001104659-26-028599.md) | [(54.4)](/filings/0001104659-26-057998.md) | [(5.7) d](/filings/0001104659-26-092672.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001558370-24-016161.md) | [0.5 d](/filings/0001104659-26-028599.md) | [0.0](/filings/0001558370-24-013697.md) | [0.0 d](/filings/0001558370-24-016160.md) | [0.0 d](/filings/0001558370-24-016161.md) | [1.2 d](/filings/0001104659-26-028599.md) | not reported | not reported | not reported | not reported | [0.2](/filings/0001104659-26-057998.md) | [0.3 d](/filings/0001104659-26-092672.md) |
| Dividends paid | $m | [2.5 d](/filings/0001558370-24-016161.md) | [2.5 d](/filings/0001104659-26-028599.md) | [2.5](/filings/0001558370-25-007623.md) | [2.5 d](/filings/0001558370-25-011083.md) | [2.5 d](/filings/0001104659-25-109181.md) | [2.5 d](/filings/0001104659-26-028599.md) | [2.5](/filings/0001104659-26-057998.md) | [2.5 d](/filings/0001104659-26-092672.md) | [2.5 d](/filings/0001104659-25-109181.md) | [2.5 d](/filings/0001104659-26-028599.md) | [2.6](/filings/0001104659-26-057998.md) | [2.5 d](/filings/0001104659-26-092672.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001104659-25-109181.md) | not reported | not reported | not reported | [0.0 d](/filings/0001104659-25-109181.md) | [0.0 d](/filings/0001104659-26-028599.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.7](/filings/0001558370-24-015047.md) | [24.7](/filings/0001558370-24-013697.md) | [24.6](/filings/0001558370-24-016160.md) | [24.6](/filings/0001558370-24-016161.md) | [24.7](/filings/0001558370-25-007623.md) | [24.7](/filings/0001558370-25-011083.md) | [24.7](/filings/0001104659-25-109181.md) | [24.7](/filings/0001104659-26-057998.md) | [24.7](/filings/0001104659-26-092672.md) | [24.6](/filings/0001104659-25-109181.md) | [24.7](/filings/0001104659-26-057998.md) | [24.8](/filings/0001104659-26-092672.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,799,072 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092672.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.